JETi Hong Kong Post Market Study (PMS)

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

February 12, 2025

Study Completion Date

February 15, 2025

Conditions
Peripheral Venous ThrombosisPeripheral Arterial ThrombosisPeripheral Arteriovenous Thrombosis
Interventions
DEVICE

JETi Hydrodynamic Thrombectomy System

The JETi Hydrodynamic Thrombectomy System is a hydro-mechanical aspiration system intended for the removal of intravascular thrombus. The system is comprised of the JETi Catheter, JETi Pump Set, and JETi Saline Drive Unit (SDU), accessory cart, suction tubing, and non-sterile canister set. The JETi System is designed to simultaneously deliver a stream of high-pressure saline via a displacement pump to the distal tip of the JETi Catheter, while aspirating thrombotic material macerated by the saline stream.

Trial Locations (4)

Unknown

Princess Margaret Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Prince of Wales Hospital, Hong Kong

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT06340763 - JETi Hong Kong Post Market Study (PMS) | Biotech Hunter | Biotech Hunter